FDA chief: We are not targeting Indian companies
This article was originally published in Scrip
Executive Summary
The fact that the FDA has increased its presence in India does not mean US regulators are scrutinizing drug makers in that country any greater than the agency does elsewhere, Commissioner Dr Margaret Hamburg declared on 21 February.